Cargando…

Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers

BACKGROUND: Central to the design of a randomised controlled trial is the calculation of the number of participants needed. This is typically achieved by specifying a target difference and calculating the corresponding sample size, which provides reassurance that the trial will have the required sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Jonathan A, Hislop, Jenni, Altman, Douglas G, Fayers, Peter, Briggs, Andrew H, Ramsay, Craig R, Norrie, John D, Harvey, Ian M, Buckley, Brian, Fergusson, Dean, Ford, Ian, Vale, Luke D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302137/
https://www.ncbi.nlm.nih.gov/pubmed/25928502
http://dx.doi.org/10.1186/s13063-014-0526-8
_version_ 1782353745327161344
author Cook, Jonathan A
Hislop, Jenni
Altman, Douglas G
Fayers, Peter
Briggs, Andrew H
Ramsay, Craig R
Norrie, John D
Harvey, Ian M
Buckley, Brian
Fergusson, Dean
Ford, Ian
Vale, Luke D
author_facet Cook, Jonathan A
Hislop, Jenni
Altman, Douglas G
Fayers, Peter
Briggs, Andrew H
Ramsay, Craig R
Norrie, John D
Harvey, Ian M
Buckley, Brian
Fergusson, Dean
Ford, Ian
Vale, Luke D
author_sort Cook, Jonathan A
collection PubMed
description BACKGROUND: Central to the design of a randomised controlled trial is the calculation of the number of participants needed. This is typically achieved by specifying a target difference and calculating the corresponding sample size, which provides reassurance that the trial will have the required statistical power (at the planned statistical significance level) to identify whether a difference of a particular magnitude exists. Beyond pure statistical or scientific concerns, it is ethically imperative that an appropriate number of participants should be recruited. Despite the critical role of the target difference for the primary outcome in the design of randomised controlled trials, its determination has received surprisingly little attention. This article provides guidance on the specification of the target difference for the primary outcome in a sample size calculation for a two parallel group randomised controlled trial with a superiority question. METHODS: This work was part of the DELTA (Difference ELicitation in TriAls) project. Draft guidance was developed by the project steering and advisory groups utilising the results of the systematic review and surveys. Findings were circulated and presented to members of the combined group at a face-to-face meeting, along with a proposed outline of the guidance document structure, containing recommendations and reporting items for a trial protocol and report. The guidance and was subsequently drafted and circulated for further comment before finalisation. RESULTS: Guidance on specification of a target difference in the primary outcome for a two group parallel randomised controlled trial was produced. Additionally, a list of reporting items for protocols and trial reports was generated. CONCLUSIONS: Specification of the target difference for the primary outcome is a key component of a randomized controlled trial sample size calculation. There is a need for better justification of the target difference and reporting of its specification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-014-0526-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4302137
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43021372015-01-23 Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers Cook, Jonathan A Hislop, Jenni Altman, Douglas G Fayers, Peter Briggs, Andrew H Ramsay, Craig R Norrie, John D Harvey, Ian M Buckley, Brian Fergusson, Dean Ford, Ian Vale, Luke D Trials Research BACKGROUND: Central to the design of a randomised controlled trial is the calculation of the number of participants needed. This is typically achieved by specifying a target difference and calculating the corresponding sample size, which provides reassurance that the trial will have the required statistical power (at the planned statistical significance level) to identify whether a difference of a particular magnitude exists. Beyond pure statistical or scientific concerns, it is ethically imperative that an appropriate number of participants should be recruited. Despite the critical role of the target difference for the primary outcome in the design of randomised controlled trials, its determination has received surprisingly little attention. This article provides guidance on the specification of the target difference for the primary outcome in a sample size calculation for a two parallel group randomised controlled trial with a superiority question. METHODS: This work was part of the DELTA (Difference ELicitation in TriAls) project. Draft guidance was developed by the project steering and advisory groups utilising the results of the systematic review and surveys. Findings were circulated and presented to members of the combined group at a face-to-face meeting, along with a proposed outline of the guidance document structure, containing recommendations and reporting items for a trial protocol and report. The guidance and was subsequently drafted and circulated for further comment before finalisation. RESULTS: Guidance on specification of a target difference in the primary outcome for a two group parallel randomised controlled trial was produced. Additionally, a list of reporting items for protocols and trial reports was generated. CONCLUSIONS: Specification of the target difference for the primary outcome is a key component of a randomized controlled trial sample size calculation. There is a need for better justification of the target difference and reporting of its specification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-014-0526-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-15 /pmc/articles/PMC4302137/ /pubmed/25928502 http://dx.doi.org/10.1186/s13063-014-0526-8 Text en © Cook et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Cook, Jonathan A
Hislop, Jenni
Altman, Douglas G
Fayers, Peter
Briggs, Andrew H
Ramsay, Craig R
Norrie, John D
Harvey, Ian M
Buckley, Brian
Fergusson, Dean
Ford, Ian
Vale, Luke D
Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers
title Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers
title_full Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers
title_fullStr Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers
title_full_unstemmed Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers
title_short Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers
title_sort specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302137/
https://www.ncbi.nlm.nih.gov/pubmed/25928502
http://dx.doi.org/10.1186/s13063-014-0526-8
work_keys_str_mv AT cookjonathana specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT hislopjenni specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT altmandouglasg specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT fayerspeter specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT briggsandrewh specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT ramsaycraigr specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT norriejohnd specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT harveyianm specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT buckleybrian specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT fergussondean specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT fordian specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT valeluked specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers
AT specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers